Psychic Structure of Opioid Addiction: Impact of Lifetime Psychiatric Problems on SCL-90-based Psychopathologic Dimensions in Heroin-dependent Patients

被引:39
作者
Pani, Pier P. [1 ]
Maremmani, Angelo G. I. [3 ,5 ]
Trogu, Emanuela [2 ]
Vigna-Taglianti, Federica [6 ,7 ]
Mathis, Federica [6 ]
Diecidue, Roberto [6 ]
Kirchmayer, Ursula [8 ]
Amato, Laura [8 ]
Davoli, Marina [8 ]
Ghibaudi, Joli [9 ]
Camposeragna, Antonella [9 ]
Saponaro, Alessio [10 ]
Faggiano, Fabrizio [11 ]
Maremmani, Icro [3 ,4 ,5 ]
机构
[1] Cagliari Publ Hlth Trust ASL Cagliari, Social & Hlth Serv, Cagliari, Sardinia, Italy
[2] Cagliari Publ Hlth Trust ASL Cagliari, Dept Psychiat, Cagliari, Sardinia, Italy
[3] Univ Pisa, Santa Chiara Univ Hosp, Vincent P Dole Dual Diag Unit, Dept Neurosci, 67 Via Roma, I-56100 Pisa, Italy
[4] G De Lisio Inst Behav Sci, Pisa, Italy
[5] Assoc Applicat Neurosci Knowledge Social Aims AU, Pietrasanta, Lucca, Italy
[6] ASLTO3, Piedmont Ctr Drug Addict Epidemiol, Grugliasco, Italy
[7] San Luigi Gonzaga Univ, Dept Clin & Biol Sci, Orbassano, Province of Tur, Italy
[8] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy
[9] Natl Coordinat Hospitality Communities CNCA, Rome, Italy
[10] Emilia Romagna Reg Hlth Serv, Reg Epidemiol Observ, Bologna, Italy
[11] Avogadro Univ, Dept Translat Med, Novara, Italy
关键词
psychopathology; addiction; opioid; psychiatric comorbidity; SCL-90;
D O I
10.1097/ADT.0000000000000072
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: By applying a Principal Component Analysis (PCA) to the items of the SCL-90 checklist, we previously investigated the psychopathologic structure of individuals with heroin addiction, finding a 5-factor aggregation of psychological/psychiatric symptoms: "Worthlessness and Being trapped,'' "Somatic Symptoms,'' "Sensitivity-Psychoticism,'' "Panic-Anxiety,'' and "Violence-Suicide.'' Our studies on this subject did not, however, explore the possible impact of comorbid psychiatric conditions on 5 psychopathologic dimensions listed above. The aim of the present study is to verify whether there is any difference in these 5 dimensions between heroin-addicted patients with (PC-HA) or without (NPC-HA) known lifetime psychiatric problems. Methods: A total of 1195 patients with heroin dependence entering a residential therapeutic community treatment were assigned to one of the 5-factor solutions yielded by Principal Component Analysis on the basis of the highest z score obtained. Differences between NPC-HA and PC-HA patients in the frequency of the 5 psychopathologic dimensions and in their severity were then analyzed by means of univariate and multivariate analyses. Results: All the SCL-90 factor scores were, from a statistical viewpoint, significantly higher in PC-HA than in NPCHA patients, but the only statistically significant differences in the frequency of the 5 psychopathological dimensions were those observed in the case of "Panic-Anxiety,'' which turned out to be higher in the PC-HA group. Stepwise discriminant analysis showed that the severity of "Somatic Symptoms'' and "Panic-Anxiety'' made these 2 factors the only ones that successfully discriminated between NPC-HA and PC-HA patients. The other SCL-90-based psychopathologic dimensions were unable to improve the value of the discrimination. Conclusions: On the basis of our results, the SCL-90-defined structure of opioid addiction may be considered to be only partly dependent on the presence of a "psychiatric'' condition. This observation adds to the previous ones that go to show the stability of the above aggregations of symptoms, irrespectively of other demographic and clinical characteristics, as well as active involvement with heroin abuse or the kind of treatment chosen. When the available evidence is considered as a whole, it seems to support the trait-dependent, rather than state-dependent, nature of the proposed factorial dimensions of the psychopathology of opioid addiction.
引用
收藏
页码:6 / 16
页数:11
相关论文
共 65 条
[1]   TOLERANCE OF LOCUS COERULEUS NEURONS TO MORPHINE AND SUPPRESSION OF WITHDRAWAL RESPONSE BY CLONIDINE [J].
AGHAJANIAN, GK .
NATURE, 1978, 276 (5684) :186-188
[2]   OPIATE WITHDRAWAL INCREASES GLUTAMATE AND ASPARTATE EFFLUX IN THE LOCUS-COERULEUS - AN IN-VIVO MICRODIALYSIS STUDY [J].
AGHAJANIAN, GK ;
KOGAN, JH ;
MOGHADDAM, B .
BRAIN RESEARCH, 1994, 636 (01) :126-130
[3]   Clustering of psychiatric and somatic illnesses in the general population: multimorbidity and socioeconomic correlates [J].
Andrade, L. H. ;
Bensenor, I. M. ;
Viana, M. C. ;
Andreoni, S. ;
Wang, Y. -P. .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2010, 43 (05) :483-491
[4]   Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial [J].
Back, Sudie E. ;
Payne, Rebecca L. ;
Wahlquist, Amy Herrin ;
Carter, Rickey E. ;
Stroud, Zachary ;
Haynes, Louise ;
Hillhouse, Maureen ;
Brady, Kathleen T. ;
Ling, Walter .
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2011, 37 (05) :313-323
[5]   Detection of VEGF-Axxxb Isoforms in Human Tissues [J].
Bates, David O. ;
Mavrou, Athina ;
Qiu, Yan ;
Carter, James G. ;
Hamdollah-Zadeh, Maryam ;
Barratt, Shaney ;
Gammons, Melissa V. ;
Millar, Ann B. ;
Salmon, Andrew H. J. ;
Oltean, Sebastian ;
Harper, Steven J. .
PLOS ONE, 2013, 8 (07)
[6]   Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective [J].
Bechara, A .
NATURE NEUROSCIENCE, 2005, 8 (11) :1458-1463
[7]   Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder [J].
Berk, M. ;
Dodd, S. ;
Kauer-Sant'Anna, M. ;
Malhi, G. S. ;
Bourin, M. ;
Kapczinski, F. ;
Norman, T. .
ACTA PSYCHIATRICA SCANDINAVICA, 2007, 116 :41-49
[8]  
Blum K., 2000, J PSYCHOACTIVE DRUGS, V32, P1, DOI [DOI 10.1080/02791072, 10.1080/02791072.2000.10736099, DOI 10.1080/02791072.2000.10736099]
[9]   Brain blood flow SPET imaging in heroin abusers [J].
Botelho, Maria Filomena ;
Relvas, Joao S. ;
Abrantes, Margarida ;
Cunha, Maria Joao ;
Marques, Tiago R. ;
Rovira, Eugenia ;
Ribeiro, Carlos A. Fontes ;
Macedo, Tice .
CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY: COCAINE, GHB, AND SUBSTITUTED AMPHETAMINES, 2006, 1074 :466-477
[10]   Co-occurring mental and substance use disorders: The neurobiological effects of chronic stress [J].
Brady, KT ;
Sinha, R .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (08) :1483-1493